JP2021520813A5 - - Google Patents
Info
- Publication number
- JP2021520813A5 JP2021520813A5 JP2020555518A JP2020555518A JP2021520813A5 JP 2021520813 A5 JP2021520813 A5 JP 2021520813A5 JP 2020555518 A JP2020555518 A JP 2020555518A JP 2020555518 A JP2020555518 A JP 2020555518A JP 2021520813 A5 JP2021520813 A5 JP 2021520813A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- nucleic acid
- chimeric receptor
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18166498 | 2018-04-10 | ||
| EP18166498.8 | 2018-04-10 | ||
| PCT/NL2019/050212 WO2019199165A1 (en) | 2018-04-10 | 2019-04-10 | Chimeric notch receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021520813A JP2021520813A (ja) | 2021-08-26 |
| JP2021520813A5 true JP2021520813A5 (enExample) | 2022-04-19 |
| JP7562417B2 JP7562417B2 (ja) | 2024-10-07 |
Family
ID=62063276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555518A Active JP7562417B2 (ja) | 2018-04-10 | 2019-04-10 | キメラノッチ受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210139556A1 (enExample) |
| EP (1) | EP3774867A1 (enExample) |
| JP (1) | JP7562417B2 (enExample) |
| KR (1) | KR20210008840A (enExample) |
| CN (1) | CN112243442A (enExample) |
| AU (1) | AU2019252878B2 (enExample) |
| CA (1) | CA3096812A1 (enExample) |
| IL (1) | IL277859A (enExample) |
| WO (1) | WO2019199165A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116790647B (zh) * | 2023-02-06 | 2024-04-16 | 森瑞斯生物科技(深圳)有限公司 | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006047878A1 (en) * | 2004-11-03 | 2006-05-11 | British Columbia Cancer Agency Branch | Cancer therapeutics and methods for their use |
| CN102112490B (zh) * | 2008-07-08 | 2014-10-22 | 昂考梅德药品有限公司 | Notch1受体结合剂和其使用方法 |
| WO2012080926A2 (en) * | 2010-12-15 | 2012-06-21 | Wyeth Llc | Anti-notch1 antibodies |
| WO2014159239A2 (en) * | 2013-03-14 | 2014-10-02 | Novartis Ag | Antibodies against notch 3 |
| KR102382905B1 (ko) * | 2014-06-04 | 2022-04-04 | 프레드 헛친슨 켄서 리서치 센터 | 노치 1 및/또는 노치 2 작용제를 사용한 줄기 세포의 확장 및 생착 |
| FR3026744B1 (fr) * | 2014-10-06 | 2024-04-19 | Hopitaux Paris Assist Publique | Methode de generation de progeniteurs de cellules t |
| EP3262166A4 (en) * | 2015-02-24 | 2018-08-15 | The Regents of The University of California | Binding-triggered transcriptional switches and methods of use thereof |
| WO2017123559A2 (en) * | 2016-01-11 | 2017-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric proteins and methods of regulating gene expression |
| CA3034093A1 (en) * | 2016-08-23 | 2018-03-01 | The Regents Of The University Of California | Proteolytically cleavable chimeric polypeptides and methods of use thereof |
| US11325957B2 (en) * | 2017-06-19 | 2022-05-10 | Cell Design Labs, Inc. | Methods and compositions for reducing the immunogenicity of chimeric notch receptors |
-
2019
- 2019-04-10 CA CA3096812A patent/CA3096812A1/en active Pending
- 2019-04-10 AU AU2019252878A patent/AU2019252878B2/en active Active
- 2019-04-10 US US17/045,829 patent/US20210139556A1/en not_active Abandoned
- 2019-04-10 KR KR1020207032411A patent/KR20210008840A/ko not_active Abandoned
- 2019-04-10 WO PCT/NL2019/050212 patent/WO2019199165A1/en not_active Ceased
- 2019-04-10 JP JP2020555518A patent/JP7562417B2/ja active Active
- 2019-04-10 EP EP19720197.3A patent/EP3774867A1/en not_active Withdrawn
- 2019-04-10 CN CN201980038222.3A patent/CN112243442A/zh active Pending
-
2020
- 2020-10-07 IL IL277859A patent/IL277859A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7227290B2 (ja) | キメラ抗原受容体、組成物及び方法 | |
| CN105384825B (zh) | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 | |
| CN105331586B (zh) | 一种包含高效杀伤启动机制的肿瘤精准t细胞及其用途 | |
| CN112074278B (zh) | Bcma-car-t细胞 | |
| JP2021528048A (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| JP2025023921A (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| JP2022500419A (ja) | 腫瘍を治療するためのナチュラルキラー細胞組成物および免疫療法の方法 | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| JP2021512614A5 (enExample) | ||
| RU2018147423A (ru) | Анти-PD-L1 и IL-2 цитокины | |
| JP7404279B2 (ja) | 様々な構築物最適化を備えたｔ細胞抗原カプラ | |
| CN109651511A (zh) | 一种靶向bcma的嵌合抗原受体及其应用 | |
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| JP2022527081A5 (enExample) | ||
| JP2019536469A5 (enExample) | ||
| TW202123964A (zh) | Ｈｌａ－ｇ特異性嵌合抗原受體、核酸、ｈｌａ－ｇ特異性嵌合抗原受體表達質體、表達ｈｌａ－ｇ特異性嵌合抗原受體細胞、其用途以及用於治療癌症之醫藥組合物 | |
| US20210388109A1 (en) | Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of solid tumors | |
| JP2022548112A5 (enExample) | ||
| JP7698581B2 (ja) | 抗メソテリン抗体、抗ｃｄ３抗体又は抗ｅｇｆｒ抗体を含む融合タンパク質、それを含む二重特異性又は三重特異性抗体、及びその使用 | |
| JP2023503567A (ja) | 抗－ｃｄ３００ｃ単クローン抗体を含むがん予防または治療用組成物 | |
| JP7810446B2 (ja) | Ｈｅｒｖ－ｋ抗体治療薬 | |
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| KR102464507B1 (ko) | 항-CD300c 단클론 항체를 포함하는 암 예방 또는 치료용 조성물 | |
| Asano et al. | Multimerization of anti‐(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers | |
| JP2024535740A5 (enExample) |